Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Alimentary Pharmacology & Therapeutics|February 12, 2025
The Lipidomic Profile Discriminates Between MASLD and MetALDKai Markus Schneider, Feng Cao, Helen Ye Rim Huang, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Clinical Epigenetics|August 5, 2025
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age accelerationEvelien Van Dijck, Steven Van Laere, Emilie Logie, et al.
BMC Gastroenterology|February 12, 2017
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infectionStefan Bourgeois, Hans Van Vlierberghe, Christophe Moreno, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
JHEP Reports : Innovation in Hepatology|February 22, 2021
NASH-related increases in plasma bile acid levels depend on insulin resistanceGuillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, et al.
Translational Gastroenterology and Hepatology|February 13, 2025
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitisAdrienne Lejeune, Peter Stärkel, Alexandre Louvet, et al.
United European Gastroenterology Journal|June 6, 2023
Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective studyAntoon Billiet, Frederik Temmerman, Walter Coudyzer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemiaSandrine Caron, An Verrijken, Ilse Mertens, et al.
Hepatology Communications|February 7, 2018
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosisGuillaume Wettstein, Jean-Michel Luccarini, Laurence Poekes, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|February 12, 2025
The Lipidomic Profile Discriminates Between MASLD and MetALDKai Markus Schneider, Feng Cao, Helen Ye Rim Huang, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Clinical Epigenetics|August 5, 2025
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age accelerationEvelien Van Dijck, Steven Van Laere, Emilie Logie, et al.
BMC Gastroenterology|February 12, 2017
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infectionStefan Bourgeois, Hans Van Vlierberghe, Christophe Moreno, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
JHEP Reports : Innovation in Hepatology|February 22, 2021
NASH-related increases in plasma bile acid levels depend on insulin resistanceGuillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, et al.
Translational Gastroenterology and Hepatology|February 13, 2025
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitisAdrienne Lejeune, Peter Stärkel, Alexandre Louvet, et al.
United European Gastroenterology Journal|June 6, 2023
Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective studyAntoon Billiet, Frederik Temmerman, Walter Coudyzer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemiaSandrine Caron, An Verrijken, Ilse Mertens, et al.
Hepatology Communications|February 7, 2018
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosisGuillaume Wettstein, Jean-Michel Luccarini, Laurence Poekes, et al.
Pageof 18